Hamel Lawrence G 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 13, 2019
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Award
Common Stock
2019-02-11+50,000→ 74,371 total - Award
Stock Option (Right to Buy)
2019-02-11+100,000→ 100,000 totalExercise: $2.51Exp: 2029-02-11→ Common Stock (100,000 underlying)
Holdings
- 29,795(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2020, February 11, 2021 and February 11, 2022.
- [F3]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.